home / articles

Articles and News Articles from the OTCMKTS, NASDAQ and NYSE markets

Now Trending
Company Name:WisdomTree Japan Hedged Equity Fund
Stock Symbol:DXJ
Market:NYSE
Website:www.wisdomtree.com
Menu
DXJ DXJ Quote DXJ Short DXJ News DXJ Articles DXJ Message Board
Get Alerts

News, Short Squeeze, Breakout and More Instantly...

Search

TSLA - California EV Subsidies Made Tesla What It Is, But Elon Musk Is Ready To Cut Them Off: 'Remove Subsidies From All Industries' | Benzinga

Tesla Inc (NASDAQ:TSLA) CEO Elon Musk and California Governor Gavin Newsom are locked in a dispute after the former announced he's moving Spac...

JNJ - Johnson & Johnson Prioritizes Sustainable Growth in M&A Amid Sector Diversification, Says Analyst | Benzinga

Wednesday, Johnson & Johnson (NYSE:JNJ) reported a second-quarter adjusted EPS of $2.82, up 10.2% Y/Y, beating the consensus of $2.70. RBC...

LLY - Johnson & Johnson Prioritizes Sustainable Growth in M&A Amid Sector Diversification, Says Analyst | Benzinga

Wednesday, Johnson & Johnson (NYSE:JNJ) reported a second-quarter adjusted EPS of $2.82, up 10.2% Y/Y, beating the consensus of $2.70. RBC...

PFE - Johnson & Johnson Prioritizes Sustainable Growth in M&A Amid Sector Diversification, Says Analyst | Benzinga

Wednesday, Johnson & Johnson (NYSE:JNJ) reported a second-quarter adjusted EPS of $2.82, up 10.2% Y/Y, beating the consensus of $2.70. RBC...

REGN - Johnson & Johnson Prioritizes Sustainable Growth in M&A Amid Sector Diversification, Says Analyst | Benzinga

Wednesday, Johnson & Johnson (NYSE:JNJ) reported a second-quarter adjusted EPS of $2.82, up 10.2% Y/Y, beating the consensus of $2.70. RBC...

ABT - Why Are Abbott Laboratories Shares Trading Lower? | Benzinga

Shares of Abbott Laboratories (NYSE:ABT) are trading lower on Thursday following the company’s second-quarter 2024 financial results. What...

ARDX - Ardelyx Files Lawsuit Over Medicare Drug Payment Rules, Claims It Will Limit Patient Access To Kidney Disease Treatment | Benzinga

Drugmaker Ardelyx Inc (NASDAQ:ARDX) has reportedly taken legal action against the U.S. Department of Health and Human Services and the Centers for ...

CI - BofA Downgrades Elevance Health On Medicaid Pressure And Lowered Peer Valuations | Benzinga

Wednesday, Elevance Health Inc. (NYSE:ELV) reported second-quarter revenues of $43.2 billion, down 0.4% year-over-year, marginally above the&n...

CNC - BofA Downgrades Elevance Health On Medicaid Pressure And Lowered Peer Valuations | Benzinga

Wednesday, Elevance Health Inc. (NYSE:ELV) reported second-quarter revenues of $43.2 billion, down 0.4% year-over-year, marginally above the&n...

ELV - BofA Downgrades Elevance Health On Medicaid Pressure And Lowered Peer Valuations | Benzinga

Wednesday, Elevance Health Inc. (NYSE:ELV) reported second-quarter revenues of $43.2 billion, down 0.4% year-over-year, marginally above the&n...

Previous 10 Next 10